Treatment of respiratory disorders using ROR-gamma inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9855229
SERIAL NO

15169325

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present patent application relates to treatment of a respiratory disorder using retinoid-related orphan receptor gamma t (ROR-gamma) modulators. Particularly, the present patent application relates to treatment of a respiratory disorder using a RORγ inhibitor, wherein the RORγ inhibitor is administered by an inhalation route to a subject in need thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLENMARK PHARMACEUTICALS S A2300 LA CHAUX-DE-FONDS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bhosale, Vikram Mansingh Mumbai, IN 6 42
Hadambar, Avinash Annaso Satara, IN 1 8
Khairatkar-Joshi, Neelima Thane, IN 58 205
Kulkarni, Abhay Navi Mumbai, IN 42 821
Lodhiya, Bhavik Jaysukhlal Rajkot, IN 1 8
Marathe, Megha Thane, IN 1 8
Shah, Daisy Manish Mumbai, IN 8 38
Thiraviam, Alamelu Mangai Navi Mumbai, IN 1 8

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 2, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 2, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00